Your browser is no longer supported. Please, upgrade your browser.
TTNP Titan Pharmaceuticals, Inc. weekly Stock Chart
Titan Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.38 Insider Own0.30% Shs Outstand94.93M Perf Week-3.72%
Market Cap15.32M Forward P/E- EPS next Y-0.15 Insider Trans0.00% Shs Float88.90M Perf Month-16.80%
Income-17.00M PEG- EPS next Q-0.04 Inst Own10.60% Short Float7.22% Perf Quarter-56.49%
Sales4.80M P/S3.19 EPS this Y7.90% Inst Trans117.53% Short Ratio1.44 Perf Half Y-44.90%
Book/sh0.02 P/B6.86 EPS next Y12.50% ROA-179.30% Target Price- Perf Year-29.60%
Cash/sh0.05 P/C2.79 EPS next 5Y- ROE- 52W Range0.11 - 0.55 Perf YTD-29.31%
Dividend- P/FCF- EPS past 5Y3.20% ROI-307.70% 52W High-74.83% Beta0.84
Dividend %- Quick Ratio1.60 Sales past 5Y-0.20% Gross Margin76.40% 52W Low21.63% ATR0.01
Employees21 Current Ratio1.80 Sales Q/Q160.00% Oper. Margin- RSI (14)35.19 Volatility10.81% 6.60%
OptionableYes Debt/Eq3.06 EPS Q/Q87.20% Profit Margin- Rel Volume2.61 Prev Close0.13
ShortableYes LT Debt/Eq2.06 EarningsAug 14 BMO Payout- Avg Volume4.46M Price0.14
Recom3.00 SMA20-9.50% SMA50-29.45% SMA200-47.05% Volume11,664,061 Change4.57%
Jun-26-19Initiated Maxim Group Buy $4
Nov-10-17Downgrade ROTH Capital Buy → Neutral
Oct-15-20 08:00AM  
Sep-24-20 09:00AM  
Sep-18-20 04:45PM  
Sep-16-20 01:05PM  
Sep-15-20 08:30AM  
Sep-14-20 08:30AM  
Aug-26-20 05:45AM  
Aug-14-20 08:45AM  
Aug-10-20 04:30PM  
Jul-08-20 08:00AM  
Jun-24-20 08:00AM  
Jun-16-20 08:00AM  
Jun-01-20 05:20AM  
May-15-20 08:45AM  
May-11-20 04:03PM  
Apr-09-20 06:15AM  
Apr-02-20 09:47PM  
Mar-31-20 12:43PM  
Mar-30-20 04:03PM  
Mar-26-20 08:00AM  
Mar-05-20 09:00AM  
Feb-18-20 08:55AM  
Jan-13-20 08:00AM  
Jan-07-20 09:15AM  
Dec-30-19 08:00AM  
Dec-17-19 10:30AM  
Dec-04-19 01:22PM  
Dec-03-19 09:00AM  
Nov-25-19 05:15AM  
Nov-14-19 04:03PM  
Nov-07-19 04:30PM  
Oct-22-19 08:00AM  
Oct-18-19 10:23AM  
Oct-16-19 09:20AM  
Oct-01-19 08:00AM  
Sep-18-19 08:00AM  
Aug-30-19 08:01PM  
Aug-23-19 11:30AM  
Aug-17-19 09:59AM  
Aug-16-19 07:33AM  
Aug-14-19 04:03PM  
Aug-09-19 05:00PM  
Aug-07-19 09:15AM  
Jul-09-19 09:00AM  
Jul-03-19 10:54AM  
Jun-26-19 09:10AM  
Jun-04-19 07:00AM  
May-29-19 02:15PM  
May-23-19 08:10AM  
May-15-19 04:08PM  
May-13-19 07:00AM  
May-08-19 08:00PM  
May-06-19 03:12PM  
Apr-29-19 07:00AM  
Apr-12-19 05:00PM  
Apr-11-19 09:45AM  
Apr-02-19 01:06AM  
Apr-01-19 05:07PM  
Mar-28-19 07:00AM  
Mar-26-19 07:00AM  
Feb-25-19 02:20PM  
Feb-08-19 09:30AM  
Feb-01-19 02:31PM  
Jan-31-19 06:36PM  
Jan-24-19 07:00AM  
Dec-21-18 12:54PM  
Dec-10-18 10:35AM  
Nov-21-18 07:25AM  
Nov-20-18 11:15AM  
Nov-14-18 04:38PM  
Nov-08-18 07:00AM  
Nov-07-18 09:30AM  
Nov-05-18 08:55AM  
Nov-02-18 10:30AM  
Oct-30-18 09:45AM  
Oct-29-18 08:00AM  
Oct-23-18 02:40PM  
Oct-22-18 08:00AM  
Oct-15-18 08:15AM  
Oct-02-18 07:00AM  
Sep-20-18 08:30PM  
Sep-10-18 07:00AM  
Aug-20-18 05:55PM  
Aug-14-18 04:55PM  
Aug-03-18 07:00AM  
Jul-02-18 04:30PM  
May-30-18 07:00AM  
May-24-18 02:03PM  
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.